KCM
EBAC

Kawa Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Kawa Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27,000
Closed -$264K – 13
2022
Q2 		$264K Hold
27,000
– – 1.23% 23
2022
Q1 		$263K Hold
27,000
– – 0.44% 43
2021
Q4 		$262K Buy
+27,000
New +$262K 0.25% 60